SCHEMBL8957276

SCHEMBL8957276

CC(C)(C)OC(=O)CN(CC(=O)OC(C)(C)C)CC(Cc1ccc(OCC(=O)NCCCCCCCCCCC(=O)O)cc1)N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.46
ITGA2B P08514 2/20 0.46
EPOR P19235 5/20 0.39
HDAC8 Q9BY41 3/20 0.37
KDM4E B2RXH2 1/20 0.36
TSHR P16473 1/20 0.36
RECQL P46063 1/20 0.36
PTPN1 P18031 1/20 0.36
PSMB1 P20618 2/20 0.36
PSMB5 P28074 2/20 0.36
PSMB2 P49721 2/20 0.36
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8957288 0.96 ITGB3 (0.44) ITGB3ITGA2BEPORHDAC8KDM4E
SCHEMBL8957356 0.80 ITGB3 (0.47) ITGB3ITGA2BEPORHDAC8KDM4E
SCHEMBL8099592 0.80 SMN1; SMN2 (0.40) ITGB3ITGA2BHDAC8TSHRPTPN1
SCHEMBL7516386 0.77 PTPN1 (0.41) ITGB3ITGA2BHDAC8PTPN1
SCHEMBL8957358 0.77 ITGB3 (0.45) ITGB3ITGA2BEPORKDM4ETSHR
SCHEMBL8335482 0.76 ACACB (0.40) KDM4EHTTSMN1; SMN2
SCHEMBL6047694 0.76 EPOR (0.40) ITGB3ITGA2BEPOR
SCHEMBL6047708 0.76 EPOR (0.40) ITGB3ITGA2BEPOR
SCHEMBL21852438 0.74 MAOB (0.38) SMN1; SMN2
SCHEMBL92706 0.74 ACACB (0.38) KDM4EHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5482700-A Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast SCHERING AKTIENGESELLSCHAFT (DE) 1996-01-09 US disclosed